Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice (original) (raw)
References
Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene. Nature351, 453–456 (1991). ArticleCAS Google Scholar
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science253, 49–53 (1991). ArticleCAS Google Scholar
Caron de Fromentel, C. & Soussi, T. TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes, Chrom. Cancer4, 1–15 (1992). ArticleCAS Google Scholar
Chang, F., Syrjanen, S., Kurvinen, K. & Syrjanen, K. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am. j. Gastroenterol.88, 174–186 (1993). CASPubMed Google Scholar
Nigro, J.M. et al. Mutations in the p53 gene occur in diverse human tumour types. Nature342, 705–708 (1989). ArticleCAS Google Scholar
Masuda, H., Miller, C., Koeffler, H.P., Battifora, H., Cline, M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. natn. Acad. Sci. U.S.A.84, 7716–7719 (1987). ArticleCAS Google Scholar
Saylors, R.L. et al. Infrequent p53 gene mutations in medulloblastomas. Cancer Res.51, 4721–4723 (1991). PubMed Google Scholar
Preudhomme, C. et al. Rare occurrence of p53 gene mutations in multiple myeloma. Br. J. Haematol.81, 440 (1992). ArticleCAS Google Scholar
Tsushita, K., Hotta, T., Ichikawa, A. & Saito, H. Mutation of p53 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukaemia. Br. J. Haematol.81, 456 (1992). ArticleCAS Google Scholar
Moll, U., Riou, G. & Levine, A.J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. natn. Acad. Sci. U.S.A.89, 7262–7266 (1992). ArticleCAS Google Scholar
Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science250, 1233–1238 (1990). ArticleCAS Google Scholar
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W. & Chang, E. Germ-line transmission of a mutated p53 gene in a cancerprone family with Li-Fraumeni syndrome. Nature348, 747–749 (1990). ArticleCAS Google Scholar
Toguchida, J. et al. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. New Engl. J. Med.326, 1301–1308 (1992). ArticleCAS Google Scholar
Malkin, D. et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. New Engl. J. Med.326, 1309–1315 (1992). ArticleCAS Google Scholar
Ben-David, Y. & Bernstein, A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell66, 831–834 (1991). ArticleCAS Google Scholar
Lavigueur, A. et al. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Molec. cell. Biol.9, 3982–3991 (1989). ArticleCAS Google Scholar
Milner, J. & Medcalf, E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell65, 765–774 (1991). ArticleCAS Google Scholar
Kern, S. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science256, 827–830 (1992). ArticleCAS Google Scholar
Farmer, G. et al. Wild-type p53 activates transcription in vitro. Nature358, 83–86 (1992). ArticleCAS Google Scholar
Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature356, 215–221 (1992). ArticleCAS Google Scholar
Clapp, N.K., Craig, A.W. & Toya, R.E. Sr. Pulmonary and hepatic oncogenesis during treatment of male RF mice with dimethylnitrosamine. J. natn Cancer Inst.41, 1213–1221 (1968). CAS Google Scholar
Livingstone, L. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell70, 923–935 (1992). ArticleCAS Google Scholar
Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. & Wahl, G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell70, 937–948 (1992). ArticleCAS Google Scholar
Kastan, M. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell71, 587–597 (1992). ArticleCAS Google Scholar
Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis. Nature362, 847–849 (1993). ArticleCAS Google Scholar
Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature362, 849–852 (1993). ArticleCAS Google Scholar
Triche, T.J. Unique features of childhood cancer. In Cancer Medicine, 3rd edn, (eds Holland, J.F. et al.) 2144–2152 (Lea & Febiger, Malvern, Philadelphia, 1993). Google Scholar
Miller, R.W. & Dalager, B. U.S. childhood deaths by cell type. J. Pediat.85, 664 (1974). ArticleCAS Google Scholar
Parkin, D.M. et al. Results from Contributing Centers—List of Tables. In International Incidence of Childhood Cancer, No. 87, 101–107 (Oxford University Press, 1988). Google Scholar
Hansen, M.F. & Cavenee, W.K. Genetics of cancer predisposition. Cancer Res.47, 5518–5527 (1987). CASPubMed Google Scholar
Fournier, P. Biotransformation of dimethylnitrosamine. J. Toxicol. Clin. Exp.10, 283–296 (1990). CASPubMed Google Scholar
Pritchard, D.J. & Butler, W.H. Apoptosis—The mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J. Pathol.158, 253–260 (1989). ArticleCAS Google Scholar
Kemp, C., Donehower, L.A., Bradley, A. & Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell74, 813–822 (1993). ArticleCAS Google Scholar
Burns, P.A. et al. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene6, 2363–2369 (1991). CASPubMed Google Scholar